Blood Platelets Market - By Platelet Type (Whole Blood Derived Platelets, Apheresis Derived Platelets), By Application (Hemophilia, Thrombocytopenia, Perioperative Indications, Platelet Function Disorders, Hemato-oncology), By End-use, & Forecast, 2023 – 2032

Blood Platelets Market Size

Blood Platelets Market size was valued at USD 5.2 billion in 2022 and is estimated to reach USD 7.7 billion by 2032. The increasing prevalence of chronic & blood related disorders across the globe is anticipated to drive the market revenue.
 

For instance, as per the American Journal of Managed Care, in 2020, a meta-analysis showed that over 1,125,000 men around the world were suffering from an inherited bleeding disorder. According to the National Center for Biotechnology Information recent research article, around 1 in 3 of all adults suffer from multiple chronic conditions (MCCs) globally. These statistics are expected to augment the blood transfusion demand in the coming years positively.
 

Additionally, the several health concerns associated with these ailments are anticipated to stimulate the adoption of blood platelets for the effective management of these disease conditions. Moreover, rising awareness regarding chronic & blood related diseases, early-stage disease diagnosis & treatment, and a surging number of healthcare settings are set to prove conducive for business growth.
 

Blood platelets are colourless blood cells that help in blood clotting and further assist in stopping the bleeding by clumping and forming plugs in blood vessel injuries. However, high risk of transmission of blood transfusion associated infections may negatively impact the blood platelets market progress. Blood and blood products can result in considerable adverse events involving inefficacy, immunologic reactions, infections, and others that can result in death & critical disability. Bacterial contamination of blood products, especially in platelets that are stored at room temperature, is the most common infectious risk of blood transfusion.
 

Transfusion–transmitted sepsis, a persistent problem in transfusion can cause serious infection & death. In low-income countries, the risk for transfusion-transmitted human immunodeficiency virus (HIV) is high attributable to lower blood screening testing in hospitals and blood banks. Hence, blood transfusion has been and continues to be a possible source of disease transmission. However, enhanced donor screening as well as improved practices of collection, handling, and storing of blood products has reduced bacterial contamination in recent years.

COVID-19 Impact

The onset of the COVID-19 pandemic was an unprecedented event impacting the public health and led to an incremental surge in the number of hospitalizations. The coronavirus outbreak proliferated the disease burden and hampered several global businesses including the healthcare sector, during 2020 & initial phase of 2021. The subsequent travel restrictions and quarantine orders have led to substantial disruptions in availability & access to wide range of healthcare services. The COVID-19 pandemic also had a detrimental impact on the medical ecosystem, pushing widespread reallocation of healthcare personnel. The COVID-19 patients and emergency services were prioritized that negatively influenced other medical practices, including blood transfusion practice.

The risk for transmitting SARS-CoV-2 infection by blood transfusion is currently considered as low. Although, COVID-19 had substantial impact on blood transfusion services, as it impacted certain aspects of transfusion such as donor eligibility, donor availability, and availability of healthcare professionals to collect, store, and channelize blood into its components. These developments affected the blood platelets market growth during the initial phase of the pandemic, in 2020.

During the initial phase of COVID-19 pandemic, improvised standard operating protocols were enacted at donor sites that affected the blood collection volume. Also, community donor events were either cancelled or postponed due to fear of infection, logistical constrains, and the time required to implement revised safety protocols. For safety, and to incorporate application of essential safety measures, blood drop-ins were restricted, and pre-booked appointments were made mandatory. The elderly population that contributes to most donations, were amongst the highly susceptible infection-prone population group that led to reduced donations.

Blood Platelets Market Trends

The growing demand for blood transfusions has stimulated the industry revenue. This significant upsurge in blood transfusion demand is owing to the rising rate of approval by the U.S. FDA for blood transfusion products comprising blood platelets, the advent of novel technologies that are assisting in blood donation & storage, etc. The increasing prevalence of blood diseases is among the key factors driving the demand for blood transfusion.
 

Further, blood centers are also keeping meticulous records, managing highly regulated manufacturing practices, supporting & participating in various clinical trials, and expanding to new product lines & therapies. The lessened risk of catching a virus or any other blood-borne disease from a blood transfusion will further stimulate the adoption of blood platelets, thereby augmenting the market share.
 

Blood Platelets Platelet Market Analysis

Based on platelet type, the blood platelets market is segmented as whole blood derived platelets and apheresis derived platelets. The whole blood derived platelets segment accounted for a revenue share of around 47% in 2022 and is expected to continue the same trend in the coming years. This segment expansion is majorly owing to the increased demand for whole blood derived platelets in healthcare settings due to its crucial role for transplant, oncology, and pediatric patients among others. Whole blood derived platelets are cost-effective, simplest, most common & flexible type of blood donation. This platelet type is employed to treat patients that require all the components of blood, such as those that have sustained significant blood loss due to surgery or trauma.
 

Based on application, the blood platelets market is segmented as hemophilia, thrombocytopenia, perioperative indications, platelet function disorders, hemato-oncology, and others. Thrombocytopenia segment is set to reach USD 3.5 billion by 2032. This high segmental share is owing to rising demand and increasing awareness related to extensive advantages delivered by the blood platelets in the precise management of thrombocytopenia. Platelet transfusion is highly indicated to treat or prevent bleeding in patients with thrombocytopenia disorder.
 

In several hospitals, the majority of platelet transfusions are delivered to non-bleeding, thrombocytopenic patients to decrease the risk of haemorrhage. The increasing prevalence of thrombocytopenia is also contributing to the segment revenue. As per the Rare Disease Advisor Council data 2022, the estimated global prevalence of immune thrombocytopenia is over 200,000 people at any one time. This disease prevalence is set to propel the adoption of the blood platelets.  
 

Based on end-use, the blood platelets market is segmented as hospitals, ambulatory surgical centers, and others. Hospitals segment is projected to reach USD 6.3 billion by 2032. This is owing to the soaring use of blood transfusion procedures in hospital settings offering enhanced outcomes is estimated to surge the patient preference for hospitals. Growing admissions with target disorders comprising chronic & blood diseases and surging disease screening initiatives coupled with the accessibility of highly skilled healthcare professionals are some other attributes that are propelling the growth of the hospital segment positively.  
 

Additionally, the higher chronic disease incidence in developed countries with robust healthcare infrastructure is projected to positively impact segment development. Surging cancer cases, infections, and blood disorder prevalence will significantly propel the diagnosis & treatment rate at hospitals. Thus, accessibility to better treatment & diagnosis coupled with the rising prevalence of these ailments and associated conditions is estimated to boost patient visits to hospitals.
 

The U.S. dominated the North America blood platelets market is anticipated to exceed USD 1.8 billion by 2032. This significant market share is attributable to several factors such as the presence of major players, an increase in the demand for blood platelets, etc. The presence of prominent players such as America’s Blood Centers, the American National Red Cross, and Blood Centers of America among others are engaged in the novel technologies adoption that facilitates the industrial expansion in the region. The high prevalence of chronic & blood diseases and the rising hospital admission in the region emphasize the growing need for blood platelets in related procedures.
 

Blood Platelets Market Share

Some of the major market players operating in the blood platelets market are:

• American National Red Cross
• Canadian Blood Services
• French Red Cross
• Japanese Red Cross Society
• European Blood Alliance 
   

Major market players are adopting strategic formulations such as forward integration, new product development, geographical expansion, and research collaborations to garner maximum industry share and promote company growth.
 

Blood Platelets Industry News:

• In August 2022, America’s Blood Centers joined the worldwide campaign encouraging all eligible donors to give blood in a global attempt to break the world record for the most blood donations. This development helped the organization in boosting its brand visibility.
   
• In May 2022, America’s Blood Centers and HOSA Future Health Professionals announced a multi-year national partnership to encourage blood donation and careers at community blood centers. As part of the agreement, America’s Blood Centers recognized HOSA chapters and state associations for outstanding achievements in the collection of blood. This partnership assisted in building the next generation of lifelong blood donors and promoted the wide variety of career opportunities at community blood centers.

Blood platelets market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD (million) and volume (Units) from 2018 to 2032 for the following segments:

Click here to Buy Section of this Report

By Platelet Type, 2018 - 2032 (USD Million & Units)

• Whole Blood Derived Platelet
• Apheresis Derived Platelets

By Application, 2018 - 2032 (USD Million)

• Hemophilia
• Thrombocytopenia
• Perioperative Indications
• Platelet Function Disorders
• Hemato-oncology
• Others

By End-use, 2018 - 2032 (USD Million)

• Hospitals
• Ambulatory Surgical Centers
• Others

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Poland
  • Sweden
  • The Netherlands
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Thailand
  • Indonesia
  • Philippines
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Chile
  • Peru
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Iran